RAPID3单独用于类风湿关节炎疾病活动度监测不足
该前瞻性观察队列纳入330例接受改善病情抗风湿药治疗的类风湿关节炎(RA)患者,评估RAPID3与DAS28-ESR的纵向关联。结果显示RAPID3与DAS28-ESR关联较弱(β=0.29,95%CI 0.24至0.35),主要反映主观成分,不能充分捕捉客观炎症征象,故单用RAPID3监测疾病活动度不足。
要点
- RAPID3与DAS28-ESR纵向关联弱(β=0.29,95%CI 0.24至0.35)。
- RAPID3与压痛关节数、患者总体评估关联较强,与肿胀关节数关联弱。
- 临床实践中不宜单用RAPID3随访RA疾病活动度。
核心结论
- RAPID3不能充分反映客观炎症征象的变化,单用RAPID3不足以在临床实践中监测RA患者的疾病活动度。
研究设计与样本
- 前瞻性观察性队列,纳入接受改善病情抗风湿药治疗的RA患者330例,平均随访10.7个月(SD 9.7),女性占67.9%。
- 采用广义估计方程检验RAPID3(0-10)与DAS28-ESR及其各成分的纵向关联,仅纳入有两次以上连续访视数据的患者。
主要发现
- RAPID3与DAS28-ESR纵向关联较弱:β=0.29(95%CI 0.24至0.35),n=207。
- RAPID3与主观成分关联较强:压痛关节数β=0.89(95%CI 0.61至1.17),患者总体评估β=0.94(95%CI 0.84至1.04)。
- RAPID3与客观成分肿胀关节数关联较弱:β=0.29(95%CI 0.17至0.41),n=172。
- RAPID3与红细胞沉降率关联差,且受性别修饰,仅在男性中显著:β=0.37(95%CI 0.08至0.67)。
临床怎么用
- 临床随访RA疾病活动度时,不应仅依赖RAPID3,需结合包含客观炎症指标(如肿胀关节数、ESR)的DAS28等综合评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To test the longitudinal association between patient-reported outcome, Routine Assessment of Patient Index Data 3 (RAPID3) and the Disease Activity Score in 28 joints that includes the erythrocyte sedimentation rate (DAS28-ESR) in routine-care patients with rheumatoid arthritis (RA). METHODS: Patients with RA treated with disease-modifying antirheumatic drugs were included in this prospective observational cohort. The longitudinal association between RAPID3 (0-10) and DAS28-ESR and its individual components (swollen joint count (SJC), erythrocyte sedimentation rate (ESR) (mm/hour), tender joint count (TJC) and patient global assessment (PGA)) was tested using generalised estimating equations in patients with more than two consecutive visits with data on RAPID3 and DAS28-ESR. Interactions between RAPID3 and gender, pain, PGA and age at baseline were tested, and if significant (p<0.20) and clinically relevant, models were fit in the corresponding strata. RESULTS: In total, 330 patients were included (mean follow-up 10.7 (SD 9.7) months, female gender 67.9%). The longitudinal association between RAPID3 and DAS28-ESR was weak (β=0.29 (95% CI 0.24 to 0.35), n=207), meaning that one unit increase in RAPID3 corresponded to a 0.29 unit increase in Disease Activity Score in 28 joints (DAS28). RAPID3 was most strongly associated with subjective (TJC: β=0.89 (95% CI 0.61 to 1.17); PGA: β=0.94 (95% CI 0.84 to 1.04)) and not with objective components of DAS28 (SJC: β=0.29 (95% CI 0.17 to 0.41), n=172). The association between RAPID3 and ESR was poor but modified by gender, being only significant in men (β=0.37 (95% CI 0.08 to 0.67)). CONCLUSIONS: These data suggest that RAPID3 does not sufficiently capture changes in objective inflammatory signs. Monitoring by RAPID3 alone is therefore insufficient to follow disease activity in patients wth RA in clinical practice.
引用
- Boone NW, Sepriano A, van der Kuy PH, et al. Routine Assessment of Patient Index Data 3 (RAPID3) alone is insufficient to monitor disease activity in rheumatoid arthritis in clinical practice. RMD Open. 2019. PMID: 31908842. doi:10.1136/rmdopen-2019-001050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。